Concepedia

Teresa Hemmerle

TH

21

Publications

930

Citations

18

H-Index

2009

Active since

Affiliations

ETH Zurich(Current)

Philochem (Switzerland)

University of Zurich

Philogen (Italy)

University Hospital Münster

Teresa Hemmerle is an author at ETH Zurich specializing in medicine, immunology, and immunotherapy.

ORCID

Top concepts

Publications per year

2009–2023

21

Publications

21

Immunocytokines are a promising immunotherapeutic approach against glioblastoma

Emanuele Puca, Manuela Silginer, Teresa Hemmerle et al. · Science Translational Medicine · 2020 · 129 citations

The Immunocytokine L19–IL2 Eradicates Cancer When Used in Combination with CTLA-4 Blockade or with L19-TNF

Kathrin Schwager, Teresa Hemmerle, David Aebischer et al. · Journal of Investigative Dermatology · 2012 · 101 citations · Full text

, , +10

The antibody-based targeted delivery of TNF in combination with doxorubicin eradicates sarcomas in mice and confers protective immunity

Teresa Hemmerle, Philipp Probst, Leonardo Giovannoni et al. · British Journal of Cancer · 2013 · 95 citations · Full text

The antibody‐based targeted delivery of interleukin‐4 and 12 to the tumor neovasculature eradicates tumors in three mouse models of cancer

Teresa Hemmerle, Dario Neri · International Journal of Cancer · 2013 · 82 citations · Full text

, , +18

Antibody-based delivery of IL4 to the neovasculature cures mice with arthritis

Teresa Hemmerle, Fabia Doll, Dario Neri · Proceedings of the National Academy of Sciences · 2014 · 69 citations · Full text

Rows per page

1–5 of 21